Found: 12
Select item for more details and to access through your institution.
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 11, p. 3235, doi. 10.1007/s10072-020-04367-9
- By:
- Publication type:
- Article
Growth hormone/ IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis.
- Published in:
- European Journal of Neurology, 2017, v. 24, n. 2, p. 446, doi. 10.1111/ene.13207
- By:
- Publication type:
- Article
Allylic Selenocyanates as Antifungal Agents Against Pathogenic Candida Species.
- Published in:
- ChemistrySelect, 2020, v. 5, n. 34, p. 10495, doi. 10.1002/slct.202002170
- By:
- Publication type:
- Article
Allylic Selenocyanates as New Agents to Combat Fusarium Species Involved with Human Infections.
- Published in:
- ChemistrySelect, 2017, v. 2, n. 35, p. 11926, doi. 10.1002/slct.201702338
- By:
- Publication type:
- Article
IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells.
- Published in:
- Oncogene, 2014, v. 33, n. 5, p. 578, doi. 10.1038/onc.2012.630
- By:
- Publication type:
- Article
One‐Pot Synthesis of α‐Diazo‐γ,δ‐unsaturated Esters as Versatile Building Blocks for Functionalized Dienes, Cyclopentenes, and 5,7‐Fused Bicycles.
- Published in:
- European Journal of Organic Chemistry, 2021, v. 2021, n. 29, p. 4174, doi. 10.1002/ejoc.202100797
- By:
- Publication type:
- Article
Structure-based design of δ-lactones for new antifungal drug development: susceptibility, mechanism of action, and toxicity.
- Published in:
- Folia Microbiologica, 2019, v. 64, n. 4, p. 509, doi. 10.1007/s12223-018-00675-y
- By:
- Publication type:
- Article
IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.
- Published in:
- International Journal of Obesity, 2015, v. 39, n. 5, p. 770, doi. 10.1038/ijo.2014.192
- By:
- Publication type:
- Article
A longitudinal real-life comparison study of natalizumab and fingolimod.
- Published in:
- Acta Neurologica Scandinavica, 2017, v. 136, n. 3, p. 217, doi. 10.1111/ane.12718
- By:
- Publication type:
- Article
Anaphylaxis to kangaroo meat – identification of a new marsupial allergen.
- Published in:
- 2007
- By:
- Publication type:
- Other
Serum IGFBP‐2 levels are associated with reduced insulin sensitivity in obese children.
- Published in:
- Clinical Obesity, 2018, v. 8, n. 3, p. 184, doi. 10.1111/cob.12245
- By:
- Publication type:
- Article